According to the National Cancer Institute, 241,740 new cases of prostate cancer will be diagnosed this year, and 28,170 men will die from the disease.
For some men, the disease will not got any worse, even if left untreated. But for others, it may worsen rapidly. So men face a difficult dilemma when they are diagnosed with prostate cancer. Leave it alone and risk their lives, or treat it — even though it might have never been a real problem — and risk their quality of life. Standard treatment for prostate cancer has been linked to serious risk of life-changing side effects, including urinary incontinence and impotence.
But a new study from researchers in London has found that men may no longer have to choose between life and quality of life. A new ultrasound therapy shows promise for treating prostate cancer without causing the unpleasant side effects linked to other prostate cancer treatments.
The experimental treatment, called high-intensity focused ultrasound (HIFU), was tried on just 41 men at University College Hospital in London. It has not been directly compared with other therapies or assessed for long-term effectiveness. Still, researchers say this new treatment could transform the future of prostate cancer care if the initial results can be repeated in larger studies.